-
1
-
-
2342448582
-
Discovery of embelin as a cell-permeable small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database
-
Nikolovska-Coleska Z., Xu L., Hu Z., Tomita Y., Li P., Roller P.P., Wang R., Fang X., Guo R., Zhang M., Lippman M.E., Yang D., Wang S. Discovery of embelin as a cell-permeable small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J. Med. Chem. 2004, 47:2430-2440.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 2430-2440
-
-
Nikolovska-Coleska, Z.1
Xu, L.2
Hu, Z.3
Tomita, Y.4
Li, P.5
Roller, P.P.6
Wang, R.7
Fang, X.8
Guo, R.9
Zhang, M.10
Lippman, M.E.11
Yang, D.12
Wang, S.13
-
2
-
-
33845883544
-
Embelin an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products
-
Ahn K.S., Sethi G., Aggarwal B.B. Embelin an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Mol. Pharmacol. 2007, 71:209-219.
-
(2007)
Mol. Pharmacol.
, vol.71
, pp. 209-219
-
-
Ahn, K.S.1
Sethi, G.2
Aggarwal, B.B.3
-
3
-
-
34548662911
-
Effect of the XIAP inhibitor embelin on TRAIL-induced apoptosis of pancreatic cancer cells
-
Mori T., Doi R., Kida A., Nagai K., Kami K., Ito D., Toyoda E., Kawaguchi Y., Uemoto S. Effect of the XIAP inhibitor embelin on TRAIL-induced apoptosis of pancreatic cancer cells. J. Surg. Res. 2007, 142:281-286.
-
(2007)
J. Surg. Res.
, vol.142
, pp. 281-286
-
-
Mori, T.1
Doi, R.2
Kida, A.3
Nagai, K.4
Kami, K.5
Ito, D.6
Toyoda, E.7
Kawaguchi, Y.8
Uemoto, S.9
-
4
-
-
67650080174
-
The XIAP inhibitor embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP
-
Siegelin M.D., Gaiser T., Siegelin Y. The XIAP inhibitor embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP. Neurochem. Int. 2009, 55:423-430.
-
(2009)
Neurochem. Int.
, vol.55
, pp. 423-430
-
-
Siegelin, M.D.1
Gaiser, T.2
Siegelin, Y.3
-
5
-
-
66349089835
-
Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis
-
Dai Y., Qiao L., Chan K.W., Yang M., Ye J., Ma J., Zou B., Gu Q., Wang J., Pang R., Lan H.Y., Wong B.C. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res. 2009, 69:4776-4783.
-
(2009)
Cancer Res.
, vol.69
, pp. 4776-4783
-
-
Dai, Y.1
Qiao, L.2
Chan, K.W.3
Yang, M.4
Ye, J.5
Ma, J.6
Zou, B.7
Gu, Q.8
Wang, J.9
Pang, R.10
Lan, H.Y.11
Wong, B.C.12
-
6
-
-
77951655077
-
Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis
-
Joy B., Sivadasan R., Abraham T.E., John M., Sobhan P.K., Seervi M., Santhoshkumar T.R. Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis. Mol. Carcinog. 2010, 49:324-336.
-
(2010)
Mol. Carcinog.
, vol.49
, pp. 324-336
-
-
Joy, B.1
Sivadasan, R.2
Abraham, T.E.3
John, M.4
Sobhan, P.K.5
Seervi, M.6
Santhoshkumar, T.R.7
-
7
-
-
68149132860
-
Micellar delivery of bicalutamide and embelin for treating prostate cancer
-
Danquah M., Li F., Duke C.B., Miller D.D., Mahato R.I. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm. Res. 2009, 26:2081-2092.
-
(2009)
Pharm. Res.
, vol.26
, pp. 2081-2092
-
-
Danquah, M.1
Li, F.2
Duke, C.B.3
Miller, D.D.4
Mahato, R.I.5
-
8
-
-
0030840464
-
STATs and gene regulation
-
Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
-
(1997)
Science
, vol.277
, pp. 1630-1635
-
-
Darnell, J.E.1
-
9
-
-
33947574564
-
Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution
-
Aggarwal B.B., Sethi G., Ahn K.S., Sandur S.K., Pandey M.K., Kunnumakkara A.B., Sung B., Ichikawa H. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann. NY Acad. Sci. 2006, 1091:151-169.
-
(2006)
Ann. NY Acad. Sci.
, vol.1091
, pp. 151-169
-
-
Aggarwal, B.B.1
Sethi, G.2
Ahn, K.S.3
Sandur, S.K.4
Pandey, M.K.5
Kunnumakkara, A.B.6
Sung, B.7
Ichikawa, H.8
-
10
-
-
0030046753
-
STATs: signal transducers and activators of transcription
-
Ihle J.N. STATs: signal transducers and activators of transcription. Cell 1996, 84:331-334.
-
(1996)
Cell
, vol.84
, pp. 331-334
-
-
Ihle, J.N.1
-
11
-
-
0037160057
-
Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain
-
Schreiner S.J., Schiavone A.P., Smithgall T.E. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. J. Biol. Chem. 2002, 277:45680-45687.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 45680-45687
-
-
Schreiner, S.J.1
Schiavone, A.P.2
Smithgall, T.E.3
-
12
-
-
69149098253
-
Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?
-
Aggarwal B.B., Kunnumakkara A.B., Harikumar K.B., Gupta S.R., Tharakan S.T., Koca C., Dey S., Sung B. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann. NY Acad. Sci. 2009, 1171:59-76.
-
(2009)
Ann. NY Acad. Sci.
, vol.1171
, pp. 59-76
-
-
Aggarwal, B.B.1
Kunnumakkara, A.B.2
Harikumar, K.B.3
Gupta, S.R.4
Tharakan, S.T.5
Koca, C.6
Dey, S.7
Sung, B.8
-
13
-
-
33750497844
-
Inflammation and cancer: how hot is the link?
-
Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., Sethi G. Inflammation and cancer: how hot is the link?. Biochem. Pharmacol. 2006, 72:1605-1621.
-
(2006)
Biochem. Pharmacol.
, vol.72
, pp. 1605-1621
-
-
Aggarwal, B.B.1
Shishodia, S.2
Sandur, S.K.3
Pandey, M.K.4
Sethi, G.5
-
14
-
-
49249128130
-
Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1
-
Ahn K.S., Sethi G., Sung B., Goel A., Ralhan R., Aggarwal B.B. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res. 2008, 68:4406-4415.
-
(2008)
Cancer Res.
, vol.68
, pp. 4406-4415
-
-
Ahn, K.S.1
Sethi, G.2
Sung, B.3
Goel, A.4
Ralhan, R.5
Aggarwal, B.B.6
-
15
-
-
33846998312
-
Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis
-
Ahn K.S., Sethi G., Krishnan K., Aggarwal B.B. Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J. Biol. Chem. 2007, 282:809-820.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 809-820
-
-
Ahn, K.S.1
Sethi, G.2
Krishnan, K.3
Aggarwal, B.B.4
-
16
-
-
0141955061
-
Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells
-
Bharti A.C., Donato N., Aggarwal B.B. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol. 2003, 171:3863-3871.
-
(2003)
J. Immunol.
, vol.171
, pp. 3863-3871
-
-
Bharti, A.C.1
Donato, N.2
Aggarwal, B.B.3
-
17
-
-
0029069540
-
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein
-
Yu C.L., Meyer D.J., Campbell G.S., Larner A.C., Carter-Su C., Schwartz J., Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995, 269:81-83.
-
(1995)
Science
, vol.269
, pp. 81-83
-
-
Yu, C.L.1
Meyer, D.J.2
Campbell, G.S.3
Larner, A.C.4
Carter-Su, C.5
Schwartz, J.6
Jove, R.7
-
18
-
-
33750632572
-
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
-
Han Y., Amin H.M., Franko B., Frantz C., Shi X., Lai R. Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Blood 2006, 108:2796-2803.
-
(2006)
Blood
, vol.108
, pp. 2796-2803
-
-
Han, Y.1
Amin, H.M.2
Franko, B.3
Frantz, C.4
Shi, X.5
Lai, R.6
-
19
-
-
0036298183
-
PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells
-
Sun S., Steinberg B.M. PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J. Gen. Virol. 2002, 83:1651-1658.
-
(2002)
J. Gen. Virol.
, vol.83
, pp. 1651-1658
-
-
Sun, S.1
Steinberg, B.M.2
-
20
-
-
0030936323
-
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
-
Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
-
(1997)
Science
, vol.275
, pp. 1943-1947
-
-
Li, J.1
Yen, C.2
Liaw, D.3
Podsypanina, K.4
Bose, S.5
Wang, S.I.6
Puc, J.7
Miliaresis, C.8
Rodgers, L.9
McCombie, R.10
Bigner, S.H.11
Giovanella, B.C.12
Ittmann, M.13
Tycko, B.14
Hibshoosh, H.15
Wigler, M.H.16
Parsons, R.17
-
21
-
-
13344295097
-
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
-
Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J.S., Freedman M., Cohen A., Gazit A., Levitzki A., Roifman C.M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996, 379:645-648.
-
(1996)
Nature
, vol.379
, pp. 645-648
-
-
Meydan, N.1
Grunberger, T.2
Dadi, H.3
Shahar, M.4
Arpaia, E.5
Lapidot, Z.6
Leeder, J.S.7
Freedman, M.8
Cohen, A.9
Gazit, A.10
Levitzki, A.11
Roifman, C.M.12
-
22
-
-
0033529704
-
Stat3 as an oncogene
-
Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogene. Cell 1999, 98:295-303.
-
(1999)
Cell
, vol.98
, pp. 295-303
-
-
Bromberg, J.F.1
Wrzeszczynska, M.H.2
Devgan, G.3
Zhao, Y.4
Pestell, R.G.5
Albanese, C.6
Darnell, J.E.7
-
23
-
-
0025819962
-
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
-
Matsushime H., Roussel M.F., Ashmun R.A., Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991, 65:701-713.
-
(1991)
Cell
, vol.65
, pp. 701-713
-
-
Matsushime, H.1
Roussel, M.F.2
Ashmun, R.A.3
Sherr, C.J.4
-
24
-
-
0037879052
-
The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update
-
Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003, 8:115-128.
-
(2003)
Apoptosis
, vol.8
, pp. 115-128
-
-
Ly, J.D.1
Grubb, D.R.2
Lawen, A.3
-
25
-
-
0034084926
-
Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone
-
Drobnjak M., Osman I., Scher H.I., Fazzari M., Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin. Cancer Res. 2000, 6:1891-1895.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 1891-1895
-
-
Drobnjak, M.1
Osman, I.2
Scher, H.I.3
Fazzari, M.4
Cordon-Cardo, C.5
-
26
-
-
0031944598
-
Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors
-
Han E.K., Lim J.T., Arber N., Rubin M.A., Xing W.Q., Weinstein I.B. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate 1998, 35:95-101.
-
(1998)
Prostate
, vol.35
, pp. 95-101
-
-
Han, E.K.1
Lim, J.T.2
Arber, N.3
Rubin, M.A.4
Xing, W.Q.5
Weinstein, I.B.6
-
27
-
-
0027717345
-
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
-
Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 1993, 143:401-409.
-
(1993)
Am. J. Pathol.
, vol.143
, pp. 401-409
-
-
Weidner, N.1
Carroll, P.R.2
Flax, J.3
Blumenfeld, W.4
Folkman, J.5
-
28
-
-
0034658698
-
STATs in oncogenesis
-
Bowman T., Garcia R., Turkson J., Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488.
-
(2000)
Oncogene
, vol.19
, pp. 2474-2488
-
-
Bowman, T.1
Garcia, R.2
Turkson, J.3
Jove, R.4
-
29
-
-
0343729328
-
Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells
-
Tenev T., Bohmer S.A., Kaufmann R., Frese S., Bittorf T., Beckers T., Bohmer F.D. Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells. Eur. J. Cell Biol. 2000, 79:261-271.
-
(2000)
Eur. J. Cell Biol.
, vol.79
, pp. 261-271
-
-
Tenev, T.1
Bohmer, S.A.2
Kaufmann, R.3
Frese, S.4
Bittorf, T.5
Beckers, T.6
Bohmer, F.D.7
-
30
-
-
0032788884
-
Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells
-
Kim H., Baumann H. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Mol. Cell Biol. 1999, 19:5326-5338.
-
(1999)
Mol. Cell Biol.
, vol.19
, pp. 5326-5338
-
-
Kim, H.1
Baumann, H.2
-
31
-
-
0036033161
-
The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation
-
Yamamoto T., Sekine Y., Kashima K., Kubota A., Sato N., Aoki N., Matsuda T. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem. Biophys. Res. Commun. 2002, 297:811-817.
-
(2002)
Biochem. Biophys. Res. Commun.
, vol.297
, pp. 811-817
-
-
Yamamoto, T.1
Sekine, Y.2
Kashima, K.3
Kubota, A.4
Sato, N.5
Aoki, N.6
Matsuda, T.7
-
32
-
-
0035913985
-
Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin
-
Gunaje J.J., Bhat G.J. Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin. Biochem. Biophys. Res. Commun. 2001, 288:252-257.
-
(2001)
Biochem. Biophys. Res. Commun.
, vol.288
, pp. 252-257
-
-
Gunaje, J.J.1
Bhat, G.J.2
-
33
-
-
0035905767
-
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
-
Irie-Sasaki J., Sasaki T., Matsumoto W., Opavsky A., Cheng M., Welstead G., Griffiths E., Krawczyk C., Richardson C.D., Aitken K., Iscove N., Koretzky G., Johnson P., Liu P., Rothstein D.M., Penninger J.M. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 2001, 409:349-354.
-
(2001)
Nature
, vol.409
, pp. 349-354
-
-
Irie-Sasaki, J.1
Sasaki, T.2
Matsumoto, W.3
Opavsky, A.4
Cheng, M.5
Welstead, G.6
Griffiths, E.7
Krawczyk, C.8
Richardson, C.D.9
Aitken, K.10
Iscove, N.11
Koretzky, G.12
Johnson, P.13
Liu, P.14
Rothstein, D.M.15
Penninger, J.M.16
-
34
-
-
0034623287
-
Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells
-
Tanuma N., Nakamura K., Shima H., Kikuchi K. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. J. Biol. Chem. 2000, 275:28216-28221.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 28216-28221
-
-
Tanuma, N.1
Nakamura, K.2
Shima, H.3
Kikuchi, K.4
-
35
-
-
13044259628
-
Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3
-
Woetmann A., Nielsen M., Christensen S.T., Brockdorff J., Kaltoft K., Engel A.M., Skov S., Brender C., Geisler C., Svejgaard A., Rygaard J., Leick V., Odum N. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc. Natl. Acad. Sci. USA 1999, 96:10620-10625.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 10620-10625
-
-
Woetmann, A.1
Nielsen, M.2
Christensen, S.T.3
Brockdorff, J.4
Kaltoft, K.5
Engel, A.M.6
Skov, S.7
Brender, C.8
Geisler, C.9
Svejgaard, A.10
Rygaard, J.11
Leick, V.12
Odum, N.13
-
36
-
-
0036797750
-
Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor-kappaB
-
Yu Z., Zhang W., Kone B.C. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor-kappaB. Biochem. J. 2002, 367:97-105.
-
(2002)
Biochem. J.
, vol.367
, pp. 97-105
-
-
Yu, Z.1
Zhang, W.2
Kone, B.C.3
-
37
-
-
0035833541
-
Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades
-
Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412:641-647.
-
(2001)
Nature
, vol.412
, pp. 641-647
-
-
Digicaylioglu, M.1
Lipton, S.A.2
-
38
-
-
0032984589
-
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
-
Catlett-Falcone R., Landowski T.H., Oshiro M.M., Turkson J., Levitzki A., Savino R., Ciliberto G., Moscinski L., Fernandez-Luna J.L., Nunez G., Dalton W.S., Jove R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999, 10:105-115.
-
(1999)
Immunity
, vol.10
, pp. 105-115
-
-
Catlett-Falcone, R.1
Landowski, T.H.2
Oshiro, M.M.3
Turkson, J.4
Levitzki, A.5
Savino, R.6
Ciliberto, G.7
Moscinski, L.8
Fernandez-Luna, J.L.9
Nunez, G.10
Dalton, W.S.11
Jove, R.12
-
39
-
-
0033052910
-
Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells
-
Nielsen M., Kaestel C.G., Eriksen K.W., Woetmann A., Stokkedal T., Kaltoft K., Geisler C., Ropke C., Odum N. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 1999, 13:735-738.
-
(1999)
Leukemia
, vol.13
, pp. 735-738
-
-
Nielsen, M.1
Kaestel, C.G.2
Eriksen, K.W.3
Woetmann, A.4
Stokkedal, T.5
Kaltoft, K.6
Geisler, C.7
Ropke, C.8
Odum, N.9
-
40
-
-
0031984216
-
BCL-X expression in multiple myeloma: possible indicator of chemoresistance
-
Tu Y., Renner S., Xu F., Fleishman A., Taylor J., Weisz J., Vescio R., Rettig M., Berenson J., Krajewski S., Reed J.C., Lichtenstein A. BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res. 1998, 58:256-262.
-
(1998)
Cancer Res.
, vol.58
, pp. 256-262
-
-
Tu, Y.1
Renner, S.2
Xu, F.3
Fleishman, A.4
Taylor, J.5
Weisz, J.6
Vescio, R.7
Rettig, M.8
Berenson, J.9
Krajewski, S.10
Reed, J.C.11
Lichtenstein, A.12
-
41
-
-
36248971578
-
The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target
-
Capalbo G., Rodel C., Stauber R.H., Knauer S.K., Bache M., Kappler M., Rodel F. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlenther Onkol. 2007, 183:593-599.
-
(2007)
Strahlenther Onkol.
, vol.183
, pp. 593-599
-
-
Capalbo, G.1
Rodel, C.2
Stauber, R.H.3
Knauer, S.K.4
Bache, M.5
Kappler, M.6
Rodel, F.7
|